外科学

Medicine & Life Sciences

1. Anastomotic Leak 11%
2. Angiodysplasia 8%
3. Ascending Colon 7%
4. Ascites 9%
5. Bacterial Translocation 7%
6. Bile Ducts 8%
7. Body Mass Index 7%
8. Breast 12%
9. Breast Implants 7%
10. Carcinoma 13%
11. Cardiac Tamponade 7%
12. Chemoradiotherapy 38%
13. Child 8%
14. Cholangiocarcinoma 21%
15. Cholecystitis 7%
16. Chronic Disease 14%
17. Cohort Studies 10%
18. Colectomy 11%
19. Colon 9%
20. Colonic Neoplasms 17%
21. Colorectal Neoplasms 23%
22. Colostomy 8%
23. Combined Modality Therapy 7%
24. Crohn Disease 21%
25. Curriculum 6%
26. dai-kenchu-to 41%
27. Dissection 9%
28. Diverticulitis 8%
29. Drug Therapy 29%
30. Erlotinib Hydrochloride 7%
31. Esophageal Neoplasms 12%
32. Esophagectomy 29%
33. Fibrosis 13%
34. Fistula 9%
35. Fluorouracil 8%
36. Focal Nodular Hyperplasia 8%
37. Gases 9%
38. Gastrectomy 82%
39. Gastroenterostomy 15%
40. Gastrointestinal Motility 6%
41. Gastrointestinal Stromal Tumors 20%
42. Hepatectomy 44%
43. Hepatic Veins 9%
44. Hepatocellular Carcinoma 82%
45. Ileitis 8%
46. Ileus 11%
47. Imatinib Mesylate 12%
48. Incidence 7%
49. Intestinal Neoplasms 7%
50. Intestinal Pseudo-Obstruction 8%
51. Intraoperative Monitoring 7%
52. Ischemic Colitis 8%
53. Japan 18%
54. Klatskin Tumor 8%
55. Laparoscopy 18%
56. Length of Stay 10%
57. Liver 100%
58. Liver Cirrhosis 9%
59. Liver Diseases 17%
60. Liver Neoplasms 11%
61. Liver Transplantation 11%
62. Lymph Node Excision 19%
63. Lymph Nodes 23%
64. Lymphadenitis 7%
65. Minimally Invasive Surgical Procedures 25%
66. Morbidity 17%
67. Neoplasm Metastasis 31%
68. Neoplasms 39%
69. Nomograms 6%
70. Observational Studies 10%
71. Operative Time 8%
72. Pathologic Constriction 16%
73. Placebos 10%
74. Plasma Cell Granuloma 7%
75. polysaccharide-K 8%
76. Portal Vein 7%
77. Postoperative Complications 8%
78. Prolapse 13%
79. Propensity Score 37%
80. Randomized Controlled Trials 7%
81. Rectal Neoplasms 70%
82. Rectocele 8%
83. Rectovaginal Fistula 8%
84. Recurrence 36%
85. Recurrent Laryngeal Nerve 7%
86. Retrospective Studies 13%
87. Robotics 62%
88. Safety 7%
89. Segmental Mastectomy 14%
90. Small Intestine 7%
91. Squamous Cell Carcinoma 18%
92. Stomach 8%
93. Stomach Neoplasms 50%
94. Surgeons 16%
95. Surgical Anastomosis 18%
96. Survival 15%
97. Survival Rate 13%
98. Therapeutics 14%
99. Tomography 11%
100. Upper Gastrointestinal Tract 6%